Skip to main content
Clinical Trials/ACTRN12612000825853
ACTRN12612000825853
Not yet recruiting
未知

A community pharmacy-based intervention to pilot the use of actigraphy in monitoring patients with sleep disorders to improve the management of sleep disorders in the community settings

Zaswiza Mohamad Noor0 sites110 target enrollmentAugust 6, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Sleep disorders
Sponsor
Zaswiza Mohamad Noor
Enrollment
110
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 6, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Zaswiza Mohamad Noor

Eligibility Criteria

Inclusion Criteria

  • 'Walk\-in' customers who present at the community pharmacy to seek help for sleep\-related disorders or have symptoms of sleep problems

Exclusion Criteria

  • Those who are not able to speak, read and write in English, unable to complete the screening, refuse to give consent, pregnant and those currently under treatment with continuous positive airway pressure (CPAP).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease Project
ACTRN12609000705280Monash450
Active, not recruiting
Not Applicable
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® [Paracetamol (500mg) and Pseudoephedrine (30mg)] on subjects with nasal congestion accompanied by headache in the setting of a common coldThe medical rationale = to investigate this combination drug in the symptomatic relief of common cold with nasal symptoms. The reduction of symptom severity may allow subjects receiving active medication to return to work or school earlier than those receiving placebo. To study the drug in it’s ‘natural environment’, community pharmacists will function as local investigators. They will include subjects with early (= 48 hours) cold symptoms of blocked nose with headache.
EUCTR2006-000058-35-BEPfizer Consumer Healthcare Comm. VA/SCA
Active, not recruiting
Not Applicable
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® (Paracetamol (500mg)/Pseudoephedrine (30mg)) on subjects with nasal congestion accompanied by headache and/or fever in the setting of a common coldMedical rationale= Investigation of combination drug Sinutab in symptomatic relief of common cold with nasal symptoms. Community pharmacists are considered as local investigators including subjects with early (= 48 hours) cold symptoms of blocked nose with headache and/or fever.
EUCTR2004-001637-41-BEPfizer Consumer Healthcare cva/sca
Completed
Phase 2
The CIVIC pilot trial: Community-based intervention to prevent serious complications following spinal cord injury in Bangladeshspinal cord injuryNeurological - Other neurological disordersPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationInjuries and Accidents - Other injuries and accidents
ACTRN12613001137785Centre for Rehabilitation of the Paralysed30
Completed
Not Applicable
Individualized intervention by community pharmacists for supporting self-care of diabetic patients: Implementation of the tool predicting poor medication adherence with collaborative interviewing
JPRN-UMIN000031668Keio University, Faculty of Pharmacy, Division of Hospital Pharmacy Science100